Anti-inflammatory effects of Lactobacillus Rahmnosus and Bifidobacterium breve on cigarette smoke activated human Macrophages

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Mortaz, Esmaeil ^a,b,c   Adcock, Ian M ^a   Ricciardolo, Fabio L M ^d   Varahram, Mohammad ^e   Jamaati, Hamidreza ^b   Velayati, Ali Akbar ^e   Folkerts, Gert ^f   Garssen, Johan ^f,g  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TURIN   (Italy)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UTRECHT UNIVERSITY   (Netherlands)

^g DANONE NUTRICIA RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; PROBIOTIC AGENT; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; SMOKE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIFIDOBACTERIUM BREVE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LACTOBACILLUS RHAMNOSUS; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THP 1 CELL LINE; WESTERN BLOTTING; BIFIDOBACTERIUM; CHEMISTRY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; SMOKE; TOBACCO; TOXICITY;

BIFIDOBACTERIUM; CELL LINE; CYTOKINES; HUMANS; LACTOBACILLUS RHAMNOSUS; MACROPHAGE ACTIVATION; MACROPHAGES; PHAGOCYTOSIS; PROBIOTICS; SMOKE; TOBACCO; TOLL-LIKE RECEPTORS;

EID: 84943229255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136455     Document Type: Article

References (59)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine. 2007;176:532-555. PMID: 17507545
2. Barnes PJ "Neutrophils find smoke attractive", Science. 2010;210:40-41.
3. Adcock IM, Caramori G, and Barnes PJ Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration. 2011;81:265-268. doi: 10.1159/000324601 PMID: 21430413
4. RennardSI and Vestbo J COPD: the dangerous underestimate of 15%. The Lancet. 2006;367:1216-1219.
5. Cosio MG, Saetta M, and Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. The New England Journal of Medicine. 2009;360:2396-2454.
6. Hogg JC, Chu F, Utokaparch S., Woods R, Elliott WM, Buzatu L, et al., "The nature of small airway obstruction in chronic obstructive pulmonary disease", The New England Journal of Medicine. 2004;350:2645-2653. PMID: 15215480
7. Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agustí AG Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J. 2005;25:647-52. PMID: 15802338
8. Barnes PJ, Hansel TT. Prospects for new drugs for chronic obstructive pulmonary disease. Lancet. 2004;364:985-96. PMID: 15364192
9. Tzanakis NE, Tsiligianni IG, and Siafakas NM. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World Journal of Gastroenterology. 2010;16:299-305. PMID: 20082474
10. Black H, Mendoza M, and Murin S. "Thoracic manifestations of inflammatory bowel disease. Chest. 2007;131:524-532. PMID: 17296657
11. Keely S, Hansbro PM. Lung-Gut Cross Talk; A Potential Mechanism for Intestinal Dysfunction in Patients With COPD. CHEST. 2014;145:198-199.
12. Darren R, Lucas B, Bernardo SR, Cheolho C, Jordan P, Yoonkyung D, et al. Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract. J. Exp. Med. 2013;210:1871-1888. doi: 10. 1084/jem.20122762 PMID: 23960190
13. Simon K, Nicholas JT, Philip MH. Pulmonary-intestinal cross-talkin mucosal inflammatory Disease. Mucosal Immunol. 2012;5:7-18. doi: 10.1038/mi.2011.55 PMID: 22089028
14. Keely S, Talley NJ and Hansbro PM. Pulmonary intestinal cross-talk inmucosal inflammatory disease. Mucosal Immunology. 2012;5:7-18. doi: 10.1038/mi.2011.55 PMID: 22089028
15. FAO/WHO. Evaluation of Health and Nutritional Properties of Probiotics in Food. Córdoba, Argentina: Food and Agriculture Organization of the United Nations and World Health Organisation. 2001;1-34.
16. Morelli L. Probiotics clinics and/or nutrition. Digest Liver Dis. 2002;34:S8-S11.
17. Caglar E, Kargul B, Tanboga I. Bacteriotherapy and probiotics role on oral health. Oral Dis. 2005;11:131-7. PMID: 15888102
18. Guarner F, Khan A, Garisch J, Eliakim R, Gangl A, Thomson A, et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October. J Clin Gastroenterol. 2011;46:468-81.
19. Isolauri E, Salminen S, Ouwehand AC. Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol. 2004;18:299-313. PMID: 15123071
20. Gorbach S L. Probiotics and gastrointestinal health. Am. J. Gastroenterol. 2000;95:S2-S4. PMID: 10634218
21. Marteau PR, De Vrese M, Cellier CJ, and J. SchrezenmeirJ. Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr 2001;73:430S-436S. PMID: 11157353
22. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ. 2012;3241361.
23. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR et al. Gastrointestinal physiology and function: the role of prebiotics and probiotics. Br J Nutr. 1998;80:147-71.
24. Verdú EF, Bercík P, Bergonzelli GE, Huang XX, Blennerhasset P, Rochat F. et al. Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of post infective gut dysfunction. Gastroenterology. 2004;127:826-37. PMID: 15362038
25. Oelschlaeger TA. Mechanisms of probiotic actions: a review. Int J Med Microbiol. 2010;300:57-62. doi: 10.1016/j.ijmm.2009.08.005 PMID: 19783474
26. Pan SJ, Kuo CH, Lam KP, Chu YT, Wang WL, Hung CH. Probiotics and allergy in children-an update review. Pediatric Allergy Immunol. 2010;21:e659-66.
27. Youn HN, Lee DH, Lee YN, Park JK, Yuk SS, Yang SY. et al. Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res. 2012;93:138-43. doi: 10.1016/j.antiviral.2011.11.004 PMID: 22120759
28. Jan RL, Yeh KC, Hsieh MH, Lin YL, Kao HF, Li PH et al. Lactobacillus gasseri suppresses Th17 proinflammatory response and attenuates allergen-induced airway inflammation in a mouse model of allergic asthma. Br J Nutr. 2011;14:1-10.
29. Tanaka A, Seki M, Yamahira S, Noguchi H, Kosai K, Toba M, et al. Lactobacillus pentosusstrain b240 suppresses pneumonia induced by Streptococcus pneumoniae in mice. Lett Appl Microbiol. 2011;53:35-43. doi: 10.1111/j.1472-765X.2011.03079.x PMID: 21554343
30. Sagar S, Vos AP, Morgan ME, Garssen J, Georgiou NA, Boon L, et al The combination of Bifido bacterium breve with non-digestible oligosaccharides suppresses airway inflammation in a murine model for chronic asthma. Biochim Biophys Acta. 2014;15:573-583.
31. Ma D, Forsythe P, and Bienenstock J. Live Lactobacillus reuteri Is Essential for the Inhibitory Effect on Tumor Necrosis Factor Alpha-Induced Interleukin-8 Expression. Infect Immun. 2004;72:5308-14. PMID: 15322027
32. Lin YP, Thibodeaux CH, Peña JA, Ferry GD, Versalovic J. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis. 2008;14:1068-83. doi: 10.1002/ibd.20448 PMID: 18425802
33. Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics, J. Nutr. 2010;140, 713S-721S. doi: 10.3945/jn. 109.113761 PMID: 20130079
34. West AP, Koblansky AA, Ghosh S. Recognition and signaling by Toll-like receptors. Annu Rev Cell Dev Biol. 2006;22:409-37. PMID: 16822173
35. Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 1992;42:1530-6.
36. Mortaz E, Henricks PA, Kraneveld AD, Givi ME, Garssen J, Folkerts G. Cigarette smoke induces the release of CXCL-8 from human bronchial epithelial cells viaTLRs and induction of the inflammasome. Biochim BiophysActa. 2011;1812:1104-10. doi: 10.1016/j.bbadis.2011.06.002 PMID: 21684332
37. Van Bergenhenegouwen J, Kraneveld AD, Rutten L, Kettelarij N, Garssen J, Vos AP. Extracellular Vesicles Modulate Host-Microbe Responses by Altering TLR2 Activity and Phagocytosis. PLoSOne. 2014;9:e89121. doi: 10.1371/journal.pone.0089121 PMID: 24586537
38. Sagar S, Morgan ME, Chen S, Vos AP, Garssen J, Van Bergenhenegouwen J, et al. Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma. Respir Res. 2014;16:15:46. doi: 10.1186/1465-9921-15-46 PMID: 24735374
39. Drevets DA, Elliott AM. Fluorescence labeling of bacteria for studies of intracellular pathogenesis. J Immunol Methods. 1995;187:69-79. PMID: 7490459
40. Mortaz E, Givi ME, Da Silva CA, Folkerts G, Redegeld FA. A relation between TGF-fi and mast cell tryptase in experimental emphysema models. Biochim BiophysActa. 2012;1822:1154-60. doi: 10.1016/j. bbadis.2012.03.006 PMID: 22481124
41. Tsung A, Tohme S, Billiar TR. High-mobility group box-1 in sterile inflammation. J Intern Med. 2014;276:425-43. doi: 10.1111/joim.12276 PMID: 24935761
42. Mortaz E, Adcock IM, Folkerts G, Barnes PJ, Paul Vos A, Garssen J. Probiotics in the management of lung diseases. Mediators Inflamm. 2013;2013:751068. doi: 10.1155/2013/751068 PMID: 23737654
43. Hougee S, Vriesema AJ, Wijering SC, Knippels LM, Folkerts G, Nijkamp FP, et al Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol. 2010;151:107-17. doi: 10.1159/000236000 PMID: 19752564
44. Mortaz E, Adcock IM, Ito K, Kraneveld AD, Nijkamp FP, Folkerts G. Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor. Eur Respir J. 2010;36:1143-54. doi: 10.1183/09031936.00062209 PMID: 19840968
45. Blidberg K, Palmberg L, Dahlén B, Lantz AS, Larsson KChemokine release by neutrophils in chronic obstructive pulmonary disease. Innate Immun. 2012;18:503-10. doi: 10.1177/1753425911423270 PMID: 21997704
46. Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:1065-72. doi: 10.1164/rccm.201110-1792OC PMID: 22427534
47. Kirkham PA, Caramori G, Casolari P, Papi AA, Edwards M, Shamji B, et al Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;1:796-802.
48. Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2007;37:748-55. PMID: 17630319
49. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol. 2003;81:289-96. PMID: 12848850
50. Stringer KA, Tobias M, O'Neill HC, Franklin CC. Cigarette smoke extract-induced suppression of caspase-3-like activity impairs human neutrophil phagocytosis. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1572-9. PMID: 17351060
51. Hosoya T, Sakai F, Yamashita M, Shiozaki T, Endo T, Ukibe K, et al Lactobacillus helveticus SBT2171 inhibits lymphocyte proliferation by regulation of the JNK signaling pathway. PLoSOne. 2014;30:e108360.
52. Miettinen M, PietiläTE, Kekkonen RA, Kankainen M, Latvala S, Pirhonen J, et al. Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages. Gut Microbes. 2012;3:510-22. doi: 10.4161/gmic.21736 PMID: 22895087
53. Di Stefano A, Caramori G, Barczyk A, Vicari C, Brun P, Zanini A, et al. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax. 2014;69:516-24. doi: 10. 1136/thoraxjnl-2012-203062 PMID: 24430176
54. Saiwichai T, Sangalangkarn V, Kawahara K, Oyama Y, Chaichalotornkul S, Narkpinit S, Harnyuttanakorn P, et al Green tea extract supplement inhibition of HMGB1 release in rats exposed to cigarette smoke. Southeast Asian J Trop Med Public Health. 2010;41:250-8. PMID: 20578506
55. Bezerra FS, Valença SS, Pires KM, Lanzetti M, Pimenta WA, Schmidt AC, et al. Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice. Respir Physiol Neurobiol. 2011;31:120-6.
56. Heijink IH, Pouwels SD, Leijendekker C, De Bruin HG, Zijlstra GJ, Van Der Vaart H, et al. Cigarette Smoke Induced DAMP Release from Necrotic Neutrophils Triggers Pro-inflammatory Mediator Release. Am J Respir Cell Mol Biol. 2015;52:554-62. doi: 10.1165/rcmb.2013-0505OC PMID: 25192219
57. Chaichalotornkul S, Nararatwanchai T, Narkpinit S, Dararat P, Kikuchi K, Maruyama I, et al Secondhand smoke exposure-induced nucleocytoplasmic shuttling of HMGB1 in a rat premature skin aging model. Biochem Biophys Res Commun. 2015;456:92-7. doi: 10.1016/j.bbrc.2014.11.040 PMID: 25446104
58. Zhang Y, Li S, Wang G, Han D, Xie X, Wu Y, et al Changes of HMGB1 and sRAGE during the recovery of COPD exacerbation. JThorac Dis. 2014;6:734-41. doi: 10.3978/j.issn. 2072-1439.2014.04.31 PMID: 24976997
59. Pouwels SD, Heijink IH, Ten Hacken NHT, Vandenabeele P, Krysko DV, Nawijn MC et al. DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunology. 2014;7:215-226. doi: 10.1038/mi.2013.77 PMID: 24150257